Almost all patients (n = 1703; 92.7%) had previously received treatment for migraine, including analgesics (78.4%), triptans (57.9%), antiemetics (47.0%), and ergot derivatives (16.6%). Of the ...

Background and Objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and vomiting during attacks may limit the usefulness of oral medications. An ...

NEW YORK (Reuters Health) - A nasal spray containing the drug zolmitriptan, which is known by the brand name Zomig, effectively relieves migraine headache in adolescents and is well tolerated, ...

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the ...

ST. PAUL, Minn. – A nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to be the most painful kind of headache with few treatment options, according to a ...

The sole question on appeal was whether it would have been obvious to make zolmitriptan into a nasal spray. The Federal Circuit agreed with the district court that the prior art taught away from ...

WASHINGTON, Aug 27 (Reuters) - A nose spray made using AstraZeneca Plc's migraine drug Zomig can help patients with painful cluster headaches, U.S. researchers said on Monday. A study of 52 people ...

BRIDGEWATER, N.J., June 29, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that a panel of three Circuit Judges of the U.S. Court of Appeals for the Federal Circuit has ...

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is currently developing an intranasal form of zolmitriptan (TRZ), a drug for relief of migraine headaches. SNBL today announces the completion and ...

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today that it has licensed from AstraZeneca the ...